GrifolsWBO:GRF +0.11%82 Days Inventory is 285.33 as of Mar. 2026, which is 6% above its 10-year median of 268.10. GuruFocus rates WBO:GRF with a GF Score™ of 82/100 and a GF Value™ of €11.00. The stock has 7 warning signs investors should review. Among 919 Drug Manufacturers companies, Grifols ranks worse than 78.24% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Grifols's Average Total Inventories for the
three
months ended in Mar. 2026 was €3,377 Mil. Grifols's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €1,080 Mil.
Hence, Grifols's Days Inventory for the
three
months ended in Mar. 2026 was 285.33.
The historical rank and industry rank for Grifols's Days Inventory or its related term are showing as below:
WBO:GRF'
s Days Inventory Range Over the Past 10 Years
Min: 257.04 Med: 268.1 Max: 298.4
Current: 263.7
During the past 13 years, Grifols's highest Days Inventory was 298.40. The lowest was 257.04. And the median was 268.10.
WBO:GRF's Days Inventory is ranked worse than 78.24% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs WBO:GRF: 263.70
Grifols's Days Inventory
declined
from Mar. 2025 (297.75) to Mar. 2026 (285.33).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Grifols's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Grifols's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.99.
Grifols (WBO:GRF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Grifols's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Grifols's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Grifols Days Inventory Related Terms
Grifols Days Inventory Historical Data
* Premium members only.
The historical data trend for Grifols's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:GRF vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Grifols's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grifols Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grifols's Days Inventory distribution charts can be found below:
* The bar in red indicates where Grifols's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grifols (WBO:GRF) has a Days Inventory of 285.33 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grifols and its competitors. This is near median its historical median of 268.10. Over the past decade, Grifols' Days Inventory has ranged from 257.04 to 298.40. According to the industry distribution chart, Grifols ranks #719 out of 919 companies in the Drug Manufacturers industry, placing it in the top 78.2%.
Is Grifols' Days Inventory too high?
Grifols' current Days Inventory of 285.33 is near median its 10-year median of 268.10. Over the past 10 years, this metric has ranged from a low of 257.04 to a high of 298.40. The Drug Manufacturers industry median Days Inventory is 164.48. Grifols' value of 285.33 is 73.5% above this industry median. Based on the distribution chart, Grifols ranks #719 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Grifols has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Grifols ranks #719 out of 919 companies for Days Inventory. This places Grifols in the lower half of its industry. The industry median Days Inventory is 164.48. Grifols' value of 285.33 is 73.5% above this benchmark. Historically, Grifols' own Days Inventory has ranged from 257.04 to 298.40 over the past decade. While the company's 10-year median is 268.10 vs. the industry median of 164.48, Grifols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grifols's current Days Inventory of 285.33 is 73.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grifols and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grifols's current Days Inventory is 285.33, which is near median its own 10-year median of 268.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (WBO:GRF) has a current Days Inventory of 285.33. The stock's GF Value™ is €11.00, compared to a current price of €9.07 — trading 17.6% below its estimated fair value. The current Days Inventory is 285.33, which is near median its 10-year median of 268.10 and 73.5% above the Drug Manufacturers industry median of 164.48. Grifols' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Grifols (WBO:GRF), the current Days Inventory is 285.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grifols (WBO:GRF) Overvalued in 2026?
Based on GuruFocus' analysis, Grifols stock appears to be undervalued.
The current stock price of €9.07 is trading 17.6% below its estimated GF Value™ of €11.00.
Key valuation signals for WBO:GRF:
Days Inventory: 285.33 (near median its 10-year median of 268.10)
GF Value™: €11.00 vs. price of €9.07 (17.6% below fair value)
Industry Position: 73.5% above the Drug Manufacturers median (#719 of 919)
No single metric tells the full story. See the WBO:GRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
82GF Score
Get the complete analysis for WBO:GRF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:GRF has been successfully added to your 
